How do long-term data inform real-world decisions in ATTR-CM?

29 August 2026 (12:50 - 13:05)

Organised by:

Video

Slides

About the speaker

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Welcome and introduction

Associate Professor R. Pfister (Cologne, DE) Professor T. Trenkwalder (Munich, DE)

Slides Video

Taking a closer look at ATTR-CM pathophysiology and therapeutic approaches

Doctor M. Maurer (New York, US)

Slides Video

Beyond treatment initiation: delivering holistic, long-term care in ATTR-CM

Doctor P. Garcia-Pavia (Majadahonda, ES)

Slides Video

Panel discussion

Translating recent evidence into clinical practice for improved outcomes in ATTR-CM - Q&A

Doctor P. Garcia-Pavia (Majadahonda, ES) Doctor M. Maurer (New York, US) Associate Professor R. Pfister (Cologne, DE) Professor T. Damy (Creteil, FR) Professor T. Trenkwalder (Munich, DE)

Slides Video

Access the full session

Translating recent evidence into clinical practice for improved outcomes in ATTR-CM

Video

The Event

ESC Congress 2026

29 August 2026 12:50 CET

You may be interested in

Congress Presentation

Turning data into decisions: insights from trials and real-world experience in ATTR-CM

12 December 2025

Congress Presentation

Long term treatment with tafamidis in ATTR-CM: 7.5 year outcomes from the phase 3 open label long-term extension study

11 May 2026

Congress Session

Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing

28 August 2026

Congress Session

Advances in amyloidosis

1 September 2024

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

ESC 365 is supported by

Explore sponsored resources